The workshop was held on behalf of the Society of Magnetic Resonance in Medicine, the Society for Magn e t ~~ Resonance Imaging, and the European Society for Magnetic Resonance in Medicine and Biology, and attracted 160 participants from 18 countries. There were 27 oral presentations and 37 poster p
Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy
✍ Scribed by Nadine Girard; Sylviane Confort Gouny; Angèle Viola; Yann Le Fur; Patrick Viout; Kathia Chaumoitre; Claude D'Ercole; Catherine Gire; Dominique Figarella-Branger; Patrick J. Cozzone
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 406 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cerebral maturation in the normal human fetal brain was investigated by in utero localized proton MR spectroscopy (^1^H MRS). Fifty‐eight subjects at 22–39 weeks of gestational age (GA) were explored. A combination of anterior body phased‐array coils (four elements) and posterior spinal coils (two to three elements) was used. Four sequences were performed (point‐resolved spectroscopy (PRESS) sequence with short and long TEs (30 and 135 ms), with and without water saturation). A significant reduction in __myo‐__inositol (myo‐Ins) and choline (Cho) levels, and an increase in N‐acetylaspartate (NAA) and creatine (Cr) content were observed with progressing age. A new finding is the detection of NAA as early as 22 weeks of GA. This result is probably related to the fact that oligodendrocytes (whether mature or not) express NAA, as demonstrated by in vitro studies. Cho and __myo‐__inositol were the predominant resonances from 22 to 30 weeks and decreased gradually, probably reflecting the variations in substrate needed for membrane synthesis and myelination. The normal MRS data for the second trimester of gestation (when fetal MRI is usually performed) reported here can help determine whether brain metabolism is altered or not, especially when subtle anatomic changes are observed on conventional images. Magn Reson Med, 2006. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Proton magnetic resonance spectroscopy ( 1 H MRS) was used to evaluate changes in cerebral metabolites in 13 patients with Cushing's syndrome (including seven with pituitary corticotroph adenomas and six with primary adrenal disease) as compared to 40 normal subjects. Data were recorded in the front
## Abstract Image localized, water‐suppressed proton magnetic resonance spectra were obtained from affected brain in patients with multiple sclerosis. In patients with moderate to severe chronic disease, spectra revealed a decreased ratio of __N__‐acetylaspartate to creatine resonance intensities.
Water-soluble metabolites extracted from 60 surgically excised samples of various brain tumors and four nontumorous lobectomized brains were measured quantitatively using in vitro high-resolution magnetic resonance spectroscopy. A detailed MR spectrum-histology correlation study in a glioblastoma wa
## Abstract Our objective was to investigate thalamic neuronal dysfunction in patients with Huntington disease (HD). We performed localized single‐voxel proton magnetic resonance spectroscopy (MRS) of the thalamus in 22 HD patients and 25 healthy individuals. The mean age of patients was 48.5 years
## Abstract A single‐voxel proton magnetic resonance spectroscopy (^1^H‐MRS) filtering strategy for in vivo detection of serine (Ser) in human brain at 7T is proposed. Spectral difference of coupled resonances arising from different subecho times of triple refocusing at a constant total echo time (